Literature DB >> 16155105

Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.

Sebastian Philipp1, Lin Cui, Barbara Ludolph, Malte Kelm, Rainer Schulz, Michael V Cohen, James M Downey.   

Abstract

Protection from a prolyl hydroxylase domain-containing enzyme (PHD) inhibitor, desferoxamine (DFO), was recently reported to be dependent on production of reactive oxygen species (ROS). Ischemic preconditioning triggers the protected state by stimulating nitric oxide (NO) production to open mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels, generating ROS required for protection. We tested whether DFO and a second PHD inhibitor, ethyl-3,4-dihydroxybenzoate (EDHB), might have similar mechanisms. EDHB and DFO increased ROS generation by 50-75% (P < 0.001) in isolated rabbit cardiomyocytes. This increase after EDHB exposure was blocked by N(omega)-nitro-L-arginine methyl ester (L-NAME), an NO synthase (NOS) inhibitor; ODQ, a guanylyl cyclase antagonist; and Rp-8-bromoguanosine-3',5'-cyclic monophosphorothioate Rp isomer, a PKG blocker, thus implicating the NO pathway in EDHB's signaling. Glibenclamide, a nonselective K(ATP) channel blocker, or 5-hydroxydecanoate, a selective mitoK(ATP) channel antagonist, also prevented EDHB's ROS production, as did blockade of mitochondrial electron transport with myxothiazol. NOS is activated by Akt. However, neither wortmannin, an inhibitor of phosphatidylinositol-3-kinase, nor Akt inhibitor blocked EDHB-induced ROS generation, indicating that EDHB initiates signaling downstream of Akt. DFO also increased ROS production, and this effect was blocked by ODQ, 5-hydroxydecanoate, and N-(2-mercaptopropionyl)glycine, an ROS scavenger. DFO increased cardiomyocyte production of nitrite, a metabolite of NO, and this effect was blocked by an inhibitor of NOS. DFO also spared ischemic myocardium in intact hearts. This infarct-sparing effect was blocked by ODQ, L-NAME, and N-(2-mercaptopropionyl)glycine. Hence, DFO and EDHB stimulate NO-dependent activation of PKG to open mitoK(ATP) channels and produce ROS, which act as second messengers to trigger entrance into the preconditioned state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155105     DOI: 10.1152/ajpheart.00472.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

1.  Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery.

Authors:  Christina Chui Wa Poon; Sai Wang Seto; Alice Lai Shan Au; Qian Zhang; Rachel Wai Sum Li; Wayne Yuk Wai Lee; George Pak Heng Leung; Siu Kai Kong; John Hok Keung Yeung; Sai Ming Ngai; Ho Pui Ho; Simon Ming Yuen Lee; Shun Wan Chan; Yiu Wa Kwan
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Ethyl 3,4-dihydroxy benzoate, a unique preconditioning agent for alleviating hypoxia-mediated oxidative damage in L6 myoblasts cells.

Authors:  Charu Nimker; Gurpreet Kaur; Anshula Revo; Pooja Chaudhary; Anju Bansal
Journal:  J Physiol Sci       Date:  2014-11-08       Impact factor: 2.781

Review 3.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

4.  Hypoxia acts through multiple signaling pathways to induce metallothionein transactivation by the metal-responsive transcription factor-1 (MTF-1).

Authors:  Annie Dubé; Jean-François Harrisson; Geneviève Saint-Gelais; Carl Séguin
Journal:  Biochem Cell Biol       Date:  2011-12       Impact factor: 3.626

Review 5.  Nitrite in organ protection.

Authors:  Tienush Rassaf; Peter Ferdinandy; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes.

Authors:  Pratibha Kamble; Krithika Selvarajan; Chandrakala Aluganti Narasimhulu; Mukesh Nandave; Sampath Parthasarathy
Journal:  Eur J Pharmacol       Date:  2012-12-07       Impact factor: 4.432

7.  HIF-1α in heart: protective mechanisms.

Authors:  Joe Wu; Ping Chen; Ying Li; Chris Ardell; Tatyana Der; Ralph Shohet; Minghua Chen; Gary L Wright
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

Review 8.  Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing.

Authors:  James D Webb; Mathew L Coleman; Christopher W Pugh
Journal:  Cell Mol Life Sci       Date:  2009-09-12       Impact factor: 9.261

Review 9.  Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.

Authors:  Andreas Daiber; Fabio Di Lisa; Matthias Oelze; Swenja Kröller-Schön; Sebastian Steven; Eberhard Schulz; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-02-04       Impact factor: 8.739

Review 10.  Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.

Authors:  Peter Fraisl; Julián Aragonés; Peter Carmeliet
Journal:  Nat Rev Drug Discov       Date:  2009-01-23       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.